• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺恶性肿瘤中的神经内分泌分化

Neuroendocrine differentiation in prostatic malignancy.

作者信息

di Sant'Agnese P A, Cockett A T

机构信息

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, New York, USA.

出版信息

Cancer. 1996 Jul 15;78(2):357-61. doi: 10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U.

DOI:10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U
PMID:8674017
Abstract

BACKGROUND

The prostatic neuroendocrine cell is a regulatory cell that produces serotonin and peptide hormones. This cell is part of a more widely dispersed diffuse neuroendocrine regulatory system known as the APUD system. Focal neuroendocrine differentiation is seen in virtually all prostate carcinomas to one degree or another. Specific malignancies that are purely neuroendocrine include small cell carcinoma and carcinoid/carcinoid-like tumors. A variety of studies suggest a possible prognostic significance of neuroendocrine differentiation in prostate carcinoma.

METHODS

The literature on the prostatic neuroendocrine cell and neuroendocrine differentiation in prostate carcinoma is reviewed.

RESULTS

Based on analogy with other better studied elements of the diffuse neuroendocrine regulatory system or APUD system, as well as the morphology and specific products produced by neuroendocrine cells, it is likely that they play an important regulatory role in the prostate. Neuroendocrine differentiation may be of prognostic significance in prostate carcinoma. Mechanisms are not well characterized at this point, but the known growth factor activity of the neuroendocrine cell products, an increase in proliferation in cells surrounding neuroendocrine cells, and a lack of androgen receptor expression in neuroendocrine cells, suggest mechanisms by which they may be of prognostic significance.

CONCLUSIONS

Neuroendocrine differentiation in prostate carcinoma may be of prognostic significance, but better methods to define neuroendocrine, differentiation are necessary. The therapeutic implications of neuroendocrine differentiation in prostate carcinoma may be of significance and need to be explored further.

摘要

背景

前列腺神经内分泌细胞是一种能产生5-羟色胺和肽类激素的调节细胞。该细胞是一个分布更为广泛的弥散神经内分泌调节系统(即APUD系统)的一部分。几乎所有前列腺癌在某种程度上都可见局灶性神经内分泌分化。纯粹的神经内分泌特异性恶性肿瘤包括小细胞癌和类癌/类癌样肿瘤。多项研究表明神经内分泌分化在前列腺癌中可能具有预后意义。

方法

对有关前列腺神经内分泌细胞及前列腺癌神经内分泌分化的文献进行综述。

结果

基于与弥散神经内分泌调节系统或APUD系统中其他研究更充分的成分的类比,以及神经内分泌细胞的形态和产生的特定产物,它们很可能在前列腺中发挥重要的调节作用。神经内分泌分化在前列腺癌中可能具有预后意义。目前其机制尚未完全明确,但神经内分泌细胞产物已知的生长因子活性、神经内分泌细胞周围细胞增殖的增加以及神经内分泌细胞中雄激素受体表达的缺乏,提示了它们可能具有预后意义的机制。

结论

前列腺癌中的神经内分泌分化可能具有预后意义,但需要更好的方法来定义神经内分泌分化。前列腺癌中神经内分泌分化的治疗意义可能很重要,需要进一步探索。

相似文献

1
Neuroendocrine differentiation in prostatic malignancy.前列腺恶性肿瘤中的神经内分泌分化
Cancer. 1996 Jul 15;78(2):357-61. doi: 10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U.
2
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.人前列腺肿瘤中神经内分泌分化的评估及临床价值
Prostate Suppl. 1998;8:43-51.
3
Neuroendocrine differentiation in prostatic carcinoma: an update.前列腺癌中的神经内分泌分化:最新进展
Prostate Suppl. 1998;8:74-9.
4
Divergent neuroendocrine differentiation in prostatic carcinoma.前列腺癌中的不同神经内分泌分化
Semin Diagn Pathol. 2000 May;17(2):149-61.
5
Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.前列腺癌中的神经内分泌分化。一项回顾性尸检研究。
Arch Pathol Lab Med. 1988 Nov;112(11):1100-5.
6
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.在LNCaP前列腺癌细胞进展过程中,白细胞介素-6经历了从与神经内分泌分化相关的生长抑制剂向伴随雄激素受体激活的刺激因子的转变。
Prostate. 2007 May 15;67(7):764-73. doi: 10.1002/pros.20553.
7
Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.在前列腺穿刺活检中,局灶性神经内分泌分化缺乏预后意义。
J Urol. 1998 Aug;160(2):406-10.
8
The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.前列腺内分泌-旁分泌(神经内分泌)调节系统与前列腺癌中的神经内分泌分化:综述及基础研究的未来方向
J Urol. 1994 Nov;152(5 Pt 2):1927-31. doi: 10.1016/s0022-5347(17)32417-5.
9
Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.前列腺的神经内分泌细胞及前列腺癌中的神经内分泌分化:形态学方面的综述
Urology. 1998 May;51(5A Suppl):121-4. doi: 10.1016/s0090-4295(98)00064-8.
10
[Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].[伴有小细胞型神经内分泌分化的前列腺腺癌]
Medicina (B Aires). 2001;61(3):322-4.

引用本文的文献

1
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?低级别前列腺癌中的胃泌素释放肽受体:它能否成为比前列腺特异性膜抗原更好的预测指标?
Front Oncol. 2021 Mar 29;11:650249. doi: 10.3389/fonc.2021.650249. eCollection 2021.
2
Primary large cell prostate neuroendocrine carcinoma with central and nephrogenic diabetes insipidus.原发性大细胞前列腺神经内分泌癌伴中枢性和肾性尿崩症。
Int Braz J Urol. 2020 Sep-Oct;46(5):859-863. doi: 10.1590/S1677-5538.IBJU.2019.0180.
3
Prognostic role of chromogranin A in castration-resistant prostate cancer: A meta-analysis.
嗜铬粒蛋白 A 在去势抵抗性前列腺癌中的预后作用:一项荟萃分析。
Asian J Androl. 2018 Nov-Dec;20(6):561-566. doi: 10.4103/aja.aja_57_18.
4
Intensity-modulated radiation therapy for small cell carcinoma of the prostate: A case report.前列腺小细胞癌的调强放射治疗:一例报告。
Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):349-353. doi: 10.1016/j.rpor.2017.06.003. Epub 2017 Jul 22.
5
Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications.多韦替尼(TKI-258)诱导前列腺癌细胞神经内分泌分化及其治疗意义
Transl Oncol. 2017 Jun;10(3):357-366. doi: 10.1016/j.tranon.2017.01.011. Epub 2017 Mar 24.
6
Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.TPD52的亚型1(PC-1)促进前列腺癌细胞的神经内分泌转分化。
Tumour Biol. 2016 Aug;37(8):10435-46. doi: 10.1007/s13277-016-4925-1. Epub 2016 Feb 5.
7
Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study.卡铂联合依托泊苷治疗转移性去势抵抗性前列腺癌:一项回顾性研究。
Mol Clin Oncol. 2015 Nov;3(6):1208-1212. doi: 10.3892/mco.2015.628. Epub 2015 Aug 31.
8
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.SRRM4的表达及REST活性丧失可能促进去势抵抗性前列腺癌神经内分泌表型的出现。
Clin Cancer Res. 2015 Oct 15;21(20):4698-708. doi: 10.1158/1078-0432.CCR-15-0157. Epub 2015 Jun 12.
9
A rare case of large cell neuroendocrine carcinoma.一例罕见的大细胞神经内分泌癌。
BMJ Case Rep. 2014 Oct 19;2014:bcr2014206403. doi: 10.1136/bcr-2014-206403.
10
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.一种用于检测γ-氨基丁酸(GABA)的荧光偶联测定法揭示了神经内分泌癌中代谢应激诱导的GABA含量调节。
PLoS One. 2014 Feb 13;9(2):e88667. doi: 10.1371/journal.pone.0088667. eCollection 2014.